节点文献

原发性肝癌患者血清SICAM-1、VEGF水平测定的临床意义

The clinical value of serum SICAM-1 and VEGF level changes in patients with primary hepatic cancer

  • 推荐 CAJ下载
  • PDF下载
  • 不支持迅雷等下载工具,请取消加速工具后下载。

【作者】 刘忠娟时步卿

【Author】 LIU Zhong-juan,SHI Bu-qing.(Ganyu County People’s Hospital,Jiangsu 222100,China)

【机构】 江苏省赣榆县人民医院检验科江苏省赣榆县人民医院检验科 222100222100

【摘要】 目的 探讨原发性肝癌患者血清SICAM- 1、VEGF水平及临床意义。方法 应用双抗体夹心EL ISA法对33例原发性肝癌患者进行血清SICAM- 1和VEGF水平测定。并以35名正常健康人作比较。结果 原发性肝癌患者血清中SICAM- 1和VEGF水平非常显著地升高(P<0 .0 1) ,且以转移者更为显著。结论 检测血清SICAM- 1和VEGF水平的变化对了解病情、指导临床实践均具有十分重要的临床价值。

【Abstract】 Objective To investiga te the changes of serum SICAM-1?VEGF lev els and their clinical significance in p atients with primary hepatic cancer.M ethods Serum SICAM-1 and VEGF levels were determined with ELISA in 33 cases o f primary hepatic cancer and 35 normal c ontrols.Results Serum SICAM-1 and VEGF levels were significantly higher in the patients than those in normal contr ols(P<0.01).Conclusion Serum SIC AM-1 and VEGF levels were closely relate d to the disease process of clinical hep atic cancer and were of prognostic value s.

  • 【文献出处】 淮海医药 ,Journal of Huaihai Medicine , 编辑部邮箱 ,2005年03期
  • 【分类号】R735.7
  • 【下载频次】49
节点文献中: 

本文链接的文献网络图示:

本文的引文网络